Ministry of Foreign Affairs-

Bangladesh National Portal

Text size A A A

Color C C C C

Last updated: 21st June 2023

Press Release

American biotechnology company Dyadic's President Mark Emalfarb calls on Foreign Minister Dr. Momen

Dhaka, 20 June 2023:

President and CEO of Dyadic International Inc, an American biotechnology company, Mr. Mark Emalfarb called on Foreign Minister Dr. A K Abdul Momen, MP at the Ministry of Foreign Affairs in Dhaka today.

During the call on, Dyadic President Mark Emalfarb informed about the initiative to increase Bangladesh's capacity in vaccine production by signing an MoU with the state-owned pharmaceutical company Essential Drugs Company Limited of Bangladesh.

The Foreign Minister said that the pharmaceutical industries of Bangladesh are producing medicines of international quality and exporting medicines at competitive prices to many countries of the world. He urged the US to take more medicines from Bangladesh and said that the US took a lot of medical equipment from Bangladesh during the Covid pandemic.

Dr. Momen said that in many countries, including the United States, the production cost and the price of medicine is very high. Therefore, the big companies of those countries can take comparative advantage through investment and technology transfer in the pharmaceutical industries of Bangladesh. In this regard, Dr. Momen thanked Mr. Mark Emalfarb for the initiative of collaboration of world-renowned biotechnology company Dyadic with the state-owned Essential Drugs Company Limited to help increase the capacity of Bangladesh in vaccine production.

It may be noted that a Memorandum of Understanding on vaccine production to be signed between Essential Drugs Company Limited and Dyadic International Inc. at the Ministry of Health in Dhaka tomorrow.

2023-06-20

Download